The Role of Th17/IL-17 on Eosinophilic Inflammation

Journal of Autoimmunity

Volumn 40, Issue 1, 2013, Pages 9-20

  Dias, Paul M ^a   Banerjee, Gautam ^a  

^a Hindustan Lever Limited   (India)

Author keywords

Cytokines; Eosinophilia; Granzyme; Hyperinflammation; Leukocyte

Indexed keywords

ENDOTOXIN; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 6; MITOGENIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL ACTIVITY; CELL POPULATION; CELL STIMULATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; DEGRANULATION; EOSINOPHIL; EOSINOPHILIA; EXPOSURE; FEMALE; HUMAN; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE; LYMPHOCYTE PROLIFERATION; MALE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SERUM FACTOR; SUPERNATANT; T LYMPHOCYTE SUBPOPULATION; TH17 CELL;

ADULT; EOSINOPHILIA; EOSINOPHILS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-5; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; TH17 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873742238     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.07.004     Document Type: Article

References (59)

1. Bystrom J., Patel S.Y., Amin K., David B.B. Dissecting the role of eosinophil cationic protein in upper airway disease. Curr Opin Allergy Clin Immunol 2012, 12:18-23.
2. Mary K., Maria L., Ingrid S., Christer J., Gunnemar S., Marie C. PI3-kinase regulates eosinophil and neutrophil degranulation in patients with allergic rhinitis and allergic asthma irrespective of allergen challenge model. Inflammation 2012, 35:230-239.
3. Nirav R.B., Prescott G.W. Human asthma phenotypes: from the clinic, to cytokines, and back again. Immunological Rev 2011, 242:220-232.
4. Hirohito K. Eosinophils: multifaceted biological properties and roles in health and disease. Immunological Rev 2011, 242:161-177.
5. Simon D., Simon H.U. Eosinophilic disorders. J Allergy Clin Immunol 2007, 119:1291-1300.
6. Barnes P.J. Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med 2010, 7:e1000220.
7. Wood L.G., Baines K.J., Fu J., Scott H.A., Gibson P.G. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest 2012, 10.1378/chest.11-1838.
8. Maclay J.D., McAllister D.A., Rabinovich R., Haq I., Maxwell S., Hartland S., et al. Systemic elastin degradation in chronic obstructive pulmonary disease. Thorax 2012, 10.1136/thoraxjnl-2011-200949.
9. Ronald A.R., Richard B., Erica L.H. Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol 2011, 11:427-435.
10. Evangelopoulos A.A., Vallianou N.G., Bountziouka V., Katsagoni C., Bathrellou E., Vogiatzakis E.D., et al. Association between serum cystatin C, monocytes and other inflammatory markers. Intern Med J 2011, 42:517-522.
11. Paige L., Jennifer L.S. Cytokine release from innate immune cells: association with diverse membrane trafficking pathways. Blood 2011, 118:9-18.
12. Stone K.D., Prussin C., Metcalfe D.D. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2010, 125:73-80.
13. Hoareau L., Bencharif K., Rondeau P., Murumalla R., Ravanan P., Tallet F., et al. Signaling pathways involved in LPS induced TNF alpha production in human adipocytes. J Inflamm 2010, 7:1-12.
14. Christopher S.S., Mark A.B. Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance. Pharmacol Ther 2011, 130:93-105.
15. Angus D.C., Mira J.P., Vincent J.L. Improving clinical trials in the critically ill. Crit Care Med 2010, 38:527-532.
16. Newman K.L., Newman L.S. Occupational causes of sarcoidosis. Curr Opin Allergy Clin Immunol 2012, 12:145-150.
17. Picard D., Janela B., Descamps V., D'Incan M., Courville P., Jacquot S., et al. Drug reaction with eosinophilia and systemic symptoms [DRESS]: a multiorgan antiviral T cell response. Sci Transl Med 2010, 2:46-62.
18. Kim E.Y., Juvet S.C., Zhang L. Regulatory CD4- CD8- double negative T cells. Meth Mol Biol 2011, 677:85-98.
19. Lanaro C., Franco-Penteado C.F., Albuqueque D.M., Saad S.T., Conran N., Costa F.F. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy. J Leuko Biol 2009, 85:235-242.
20. Okada S., Hagan J.B., Kato M., Bankers-Fulbright J.L., Hunt L.W., Gleich G.J., et al. Lidocaine and its analogues inhibit IL-5-mediated survival and activation of human eosinophils. J Immunol 1998, 160:4010-4017.
21. Herve L., Michele F., Sylvie G., Yves R., Marie-Lise G. A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated Cytotoxicity. J Immun Meth 2001, 253:177-187.
22. Manise M., Schleich F., Quaedvlieg V., Moermans C., Henket M., Sele J., et al. Disturbed cytokine production at the systemic level in difficult-to-control atopic asthma: evidence for raised Interleukin-4 and decreased Interferon-γ release following Lipopolysaccharide stimulation. Int Arch Allergy Immunol 2012, 158:1-8.
23. Wong C.K., Ho C.Y., Ko F.W., Chan C.H., Ho A.S., Hui D.S., et al. Proinflammatory cytokines [IL-17, IL-6, IL-18 and IL-12] and Th cytokines [IFN-γ, IL-4, IL-10 and IL-13] in patients with allergic asthma. Clin Exp Immunol 2001, 125:177-183.
24. Molet S., Hamid Q., Davoine F., Nutku E., Taha R., Pagé N., et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001, 108:430-438.
25. Heon P., Zhaoxia L., Xuexian O.Y., Seon H.C., Roza N., Yi-Hong W., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141.
26. Ciprandi G., De Amici M., Murdaca G., Fenoglio D. Serum interleukin-17 levels are related to clinical severity in allergic rhinitis. Allergy 2009, 64:1375-1378.
27. Benjamin J.M., Nicole R.F., Andrew B.S., Amir A.S., Roderick A.M., Eric S.W., et al. Interleukin-17 drives pulmonary eosinophilia following repeated exposure to Aspergillus fumigatus conidia. Infect Immunol 2012, 80:1424-1436.
28. Mike B., Christopher B., Ian P., Wardlaw A.J. TNF-α in asthma. Curr Opin Pharmacol 2007, 7:279-282.
29. Jansky L., Reymanova P., Kopecky J. Dynamics of cytokine production in human peripheral blood mononuclear cells stimulated by LPS or infected by Borreli. Physiol Res 2003, 52:593-598.
30. Jiang H.R., Muckersie E., Robertson M., Xu H., Liversidge J., Forrester J.V. Secretion of interleukin-10 or interleukin-12 by LPS-activated dendritic cells is critically dependent on time of stimulus relative to initiation of purified DC culture. J Leuko Biol 2002, 72:978-985.
31. Bartosz S., Mariola K.S., Peter K., Damo X., Liew Y.F. IL-33 Exacerbates eosinophil-mediated airway inflammation. J Immunol 2010, 185:3472-3480.
32. Bottoms S.E., Howell J.E., Reinhardt A.K., Evans I.C., McAnulty R.J. TGF-β isoform specific regulation of airway inflammation and remodelling in a murine model of asthma. PLoS ONE 2010, 5:e9674.
33. Zuyderduyn S., Hiemstra P.S., Rabe K.F. TGF-β differentially regulates TH2 cytokine induced eotaxin and eotaxin-3 release by human airway smooth muscle cells. J Allergy Clin Immunol 2004, 114:791-798.
34. Kadin M., Butmarc J., Elovic A., Wong D. Eosinophils are the major source of TGF-β1 in nodular sclerosing Hodgkin's disease. Am J Pathol 1993, 142:11-16.
35. Zuany-Amorim C., Créminon C., Nevers M.C., Nahori M.A., Vargaftig B.B., Pretolani M. Modulation by IL-10 of antigen-induced IL-5 generation, and CD4+ T lymphocyte and eosinophil infiltration into the mouse peritoneal cavity. J Immunol 1996, 157:377-384.
36. Jennifer K., Jane E.B., Douglas S.R., Clare M.L. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. JEM 2005, 202:1539-1547.
37. Davila E., Kolls J. A " Toll" for Th17 cell expansion. J Leuko Biol 2010, 88:5-7.
38. McAleer J.P., Liu B., Li Z., Ngoi S.M., Dai J., Oft M., et al. Potent intestinal Th17 priming through peripheral lipopolysaccharide-based immunization. J Leuko Biol 2010, 88:21-23.
39. Wendy L.H. A role for epithelial γδ T cells in tissue repair. Immunol Res 2000, 21:63-69.
40. Bank I., Reshef A., Beniaminov M., Rosenthal E., Rechavi G., Monselise Y. Role of γδ Tcells in a patient with CD4+ CD3- lymphocytosis, hypereosinophilia, and high levels of IgE. J Allergy Clin Immunol 1998, 102:621-630.
41. Shibata K., Yamada H., Nakamura R., Sun X., Itsumi M., Yoshikai Y. Identification of CD25+ γδ T cells as fetal thymus-derived naturally occurring IL-17 producers. J Immunol 2008, 181:5940-5947.
42. Honoratt M.C., Neri S., Cattini L., Faccini A. IL-17 enhances the susceptibility of U-2 OS osteosarcoma cells to NK cell lysis. Clin Exp Immunol 2003, 133:344-349.
43. Roberts R.L., Ank B.J., Stiehm E.R. Human eosinophils are more toxic than neutrophils in antibody-independent killing. J Allergy Clin Immunol 1991, 87:1105-1115.
44. Zarcone D., Tilden A.B., Friedman H.M., Grossi C.E. Human leukemia-derived cell lines and clones as models for mechanistic analysis of natural killer cell-mediated cytotoxicity. Cancer Res 1987, 47:2674-2682.
45. Abhilash D.P., Zaidoon A., Rune A.H., Trygve H., Hanne F.H., Johannes N., et al. Identification of human NK17/NK1 cells. PLoS ONE 2011, 6:e26780-e26787.
46. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Annu Rev Immunol 2009, 27:485-517.
47. Andrew M.L., Cory J.R., Ritika K., Jennifer Y.W., MaryBeth R., Srilakshmi Y., et al. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 2011, 187:490-500.
48. Ario T., Takashi D., Hisakata Y., Kensuke S., Risa N., Masatoshi E., et al. IL-17 production by γδ T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette-Guerin treatment against bladder cancer. Eur J Immunol 2011, 41:246-251.
49. Lucie R., Francois H., Carlos C., Yu Y., Julie B., Ron O., et al. IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol 2010, 184:4531-4537.
50. Teunissen M.B., Koomen C.W., de Waal Malefyt R., Wierenga E.A., Bos J.D. Interleukin-17 and Interferon-γ synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol 1998, 111:645-649.
51. Bruce S.B., Francis W.L., Michael A.G., Walter N.S., Sherry A.S., Claudia P.D., et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 1991, 173:1553-1556.
52. Yamaguchi Y., Suda T., Ohta S., Tominaga K., Miura Y., Kasahara T. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood 1991, 78:2542-2547.
53. Rosas M., Dijkers P.F., Lindemans C.L., Lammers J.J., Koenderman L., Coffer P.J. IL-5-mediated eosinophil survival requires inhibition of GSK-3 and correlates with β-catenin relocalization. J Leuko Biol 2006, 80:186-195.
54. Doreau A., Belot A., Bastid J., Riche B., Trescol-Biemont M.C., Ranchin B., et al. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 2009, 10:778-785.
55. Tsuda K., Maeda T., Tominaga A., Watanabe Y., Miyazaki E., Enzan H., et al. Eosinophil-induced liver injury: an experimental model using IL-5 transgenic mice. J Hepatol 2001, 34:270-277.
56. Leckie M.J., ten Brinke A., Khan J., Diamant Z., O'Connor B.J., Walls C.M., et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000, 356:2144-2148.
57. Flood-Page P., Swenson C., Faiferman I., Matthews J., Williams M., Brannick L., et al. A study to evaluate safety and efficacy of Mepolizumab in patients with moderate persistent asthma. Am J Resp Crit Care Med 2007, 176:1062-1071.
58. Kim C.K., Callaway Z., Kim D.W., Kita H. Eosinophil degranulation is more important than eosinophilia in identifying asthma in chronic cough. J Asthma 2011, 48:994-1000.
59. Legrand F., Driss V., Delbeke M., Loiseau S., Hermann E., Dombrowicz D., et al. Human eosinophils exert TNF-α and granzyme A-mediated tumoricidal activity toward colon carcinoma cells. J Immunol 2010, 185:7443-7451.